These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 13332310)
1. The use of reserpine (serpasil) in psychiatry. MCGRATH SD; RYAN JP; FENNELLY JJ J Ir Med Assoc; 1956 Jul; 39(229):1-4. PubMed ID: 13332310 [No Abstract] [Full Text] [Related]
2. The effect of reserpine (serpasil) on the chronic disturbed schizophrenic: a comparative study of Rauwolfia alkaloids and electroconvulsive therapy. NAIDOO D J Nerv Ment Dis; 1956 Jan; 123(1):1-13. PubMed ID: 13346356 [No Abstract] [Full Text] [Related]
6. The effect of reserpine on chronic schizophrenia. WODRASKA TW Med Times; 1955 Oct; 83(10):1029-33. PubMed ID: 13264900 [No Abstract] [Full Text] [Related]
7. [The Rauwolfia alkaloid, reserpine (serpasil) in psychiatry]. MIELKE FA Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1956; 194(3):263-88. PubMed ID: 13328093 [No Abstract] [Full Text] [Related]
8. Reserpine alone and as an adjunct to psychotherapy in the treatment of schizophrenia. COWDEN RC; ZAX M; SPROLES JA AMA Arch Neurol Psychiatry; 1955 Nov; 74(5):518-22. PubMed ID: 13268118 [No Abstract] [Full Text] [Related]
10. Treatment of chronic schizophrenic reactions with reserpine. HOLLISTER LE; KRIEGER GE; KRINGEL A; ROBERTS RH Ann N Y Acad Sci; 1955 Apr; 61(1):92-100. PubMed ID: 14377276 [No Abstract] [Full Text] [Related]
11. Effects of chlorpromazine and reserpine in chronic schizophrenic patients. FREEMAN H; ARNOLD AL; CLINE HS Dis Nerv Syst; 1956 Jul; 17(7):213-9. PubMed ID: 13330613 [No Abstract] [Full Text] [Related]
12. Clinical use of reserpine in psychiatry: comparison with chlorpromazine. BLEULER M; STOLL WA Ann N Y Acad Sci; 1955 Apr; 61(1):167-73. PubMed ID: 14377284 [No Abstract] [Full Text] [Related]
13. The use of reserpine in shock-reversible patients and shock-resistant patients. TASHER DC; CHERMAK MW Ann N Y Acad Sci; 1955 Apr; 61(1):108-16. PubMed ID: 14377278 [No Abstract] [Full Text] [Related]
14. Preliminary investigations on the influence of reserpine therapy on adrenocortical function in schizophrenia. BOSCOTT RJ; JEAVONS M; KAR AB Experientia; 1956 Jul; 12(7):271. PubMed ID: 13344446 [No Abstract] [Full Text] [Related]
15. Comparison of chlorpromazine and reserpine in treatment of schizophrenia; a study of four hundred cases. KURLAND AA AMA Arch Neurol Psychiatry; 1956 May; 75(5):510-3. PubMed ID: 13312733 [No Abstract] [Full Text] [Related]
16. [Psychiatric experiences with megaphen (largactil) and the Rauwolfia alkaloid serpasil with special reference to Parkinson's psychomotor syndrome]. HAASE HJ Nervenarzt; 1955 Dec; 26(12):507-10. PubMed ID: 13297074 [No Abstract] [Full Text] [Related]
17. [Therapeutic application of reserpine (serpasil) in psychiatry]. BUKOWCZYK A Neurol Neurochir Psychiatr Pol; 1956; 6(1):73-80. PubMed ID: 13334750 [No Abstract] [Full Text] [Related]
18. Behavioral changes of chronic schizophrenics in response to reserpine. MCDONALD RE; ELLSWORTH RB; ENISS J AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):575-8. PubMed ID: 13325987 [No Abstract] [Full Text] [Related]
19. Effect of reserpine and open-ward privileges on chronic schizophrenics. PENMAN AS; DREDGE TE AMA Arch Neurol Psychiatry; 1956 Jul; 76(1):42-9. PubMed ID: 13338908 [No Abstract] [Full Text] [Related]
20. A new medical adjunct to the treatment of alcoholism; the use of reserpine (serpasil). GRANDON RC; HEFFLEY W; HENSEL T; BASHORE S Am Pract Dig Treat; 1956 Feb; 7(2):231-4. PubMed ID: 13283251 [No Abstract] [Full Text] [Related] [Next] [New Search]